Bionano Genomics, Inc.
BNGO
$1.16
$0.010.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.95M | 7.37M | 6.73M | 6.46M | 8.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.95M | 7.37M | 6.73M | 6.46M | 8.16M |
| Cost of Revenue | 4.55M | 4.00M | 3.26M | 3.52M | 4.75M |
| Gross Profit | 3.40M | 3.37M | 3.48M | 2.94M | 3.42M |
| SG&A Expenses | 8.71M | 9.06M | 8.35M | 9.03M | 11.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.49M | 15.91M | 14.53M | 14.92M | 19.97M |
| Operating Income | -8.54M | -8.54M | -7.80M | -8.47M | -11.80M |
| Income Before Tax | -7.90M | -8.49M | -6.85M | -3.10M | -20.12M |
| Income Tax Expenses | 35.00K | 14.00K | 10.00K | 7.00K | 1.00K |
| Earnings from Continuing Operations | -7.93M | -8.50M | -6.86M | -3.10M | -20.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.93M | -8.50M | -6.86M | -3.10M | -20.13M |
| EBIT | -8.54M | -8.54M | -7.80M | -8.47M | -11.80M |
| EBITDA | -6.35M | -6.11M | -5.37M | -5.98M | -9.56M |
| EPS Basic | -0.77 | -1.59 | -1.99 | -1.15 | -12.23 |
| Normalized Basic EPS | -0.48 | -0.99 | -1.24 | -0.72 | -4.80 |
| EPS Diluted | -0.77 | -1.59 | -1.99 | -1.15 | -12.23 |
| Normalized Diluted EPS | -0.48 | -0.99 | -1.24 | -0.72 | -4.80 |
| Average Basic Shares Outstanding | 10.29M | 5.34M | 3.44M | 2.69M | 1.65M |
| Average Diluted Shares Outstanding | 10.29M | 5.34M | 3.44M | 2.69M | 1.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |